YBX1 and ovarian carcinoma: Acquired cisplatin resistance was shown to be associated with increased nuclear localisation of YB-1 in ovarian cancer cell lines [53] and YB-1 was suggested to contribute to cisplatin resistance via the regulation of MDR1 expression in oesophageal squamous cell carcinoma and neuroblastoma cells [54, 55].